Systemic and intraocular uptake of spantide, a tachykinin antagonist, following topical application to the rabbit eye
- 28 January 1990
- journal article
- research article
- Published by Elsevier in Experimental Eye Research
- Vol. 50 (1) , 21-26
- https://doi.org/10.1016/0014-4835(90)90006-g
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Substance P, neurokinin A and neurokinin B in the ocular response to injury in the rabbitBritish Journal of Pharmacology, 1988
- Blockade of sensory nerve mediated contraction of the rabbit iris sphincter by a series of novel tachykinin antagonistsRegulatory Peptides, 1988
- Biological evaluation of substance P antagonistsBritish Journal of Pharmacology, 1984
- Long-term administration of a substance P antagonist, (D-Pro2, D-Trp7,9)-SP, abolishes the response to ocular traumaCellular and Molecular Life Sciences, 1984
- Conversion of substance P to C-terminal fragments in human plasmaRegulatory Peptides, 1983
- Ocular responses evoked by capsaicin and prostaglandin E2 are inhibited by a substance P antagonistCellular and Molecular Life Sciences, 1983
- Bradykinin contracts the pupillary sphincter and evokes ocular inflammation through release of neuronal substance PEuropean Journal of Pharmacology, 1983
- A Substance P Antagonist, [D-Pro 2 , D-Trp 7,9 ]SP, Inhibits Inflammatory Responses in the Rabbit EyeScience, 1981
- Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasationNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1979
- Penetration Routes of Topically Applied Eye MedicationsAmerican Journal of Ophthalmology, 1978